Author:
Guo Qianqian,Zhou Yi,Ni Haiwei,Niu Miaomiao,Xu Shengtao,Zheng Lufeng,Zhang Wenzhou
Funder
National Natural Science Foundation of China
Henan Province Science and Technology Research Project
Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions
Publisher
Springer Science and Business Media LLC
Reference52 articles.
1. Ferlay JEM, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F. Global Cancer Observatory: Cancer Today. : Lyon, France: International Agency for Research on Cancer; (2020) [ https://gco.iarc.fr/today
2. Van Cutsem E, Sagaert X, Topal B, Haustermans K, Prenen H. Gastric cancer. Lancet. 2016;388(10060):2654–64.
3. Zhang R, Liu L, Wang F, Zhao W, Liu K, Yu H, et al. AKAP8L enhances the stemness and chemoresistance of gastric cancer cells by stabilizing SCD1 mRNA. Cell Death Dis. 2022;13(12):1041.
4. Uchihara T, Miyake K, Yonemura A, Komohara Y, Itoyama R, Koiwa M, et al. Extracellular vesicles from Cancer-Associated fibroblasts containing annexin A6 induces FAK-YAP activation by stabilizing β1 integrin, enhancing Drug Resistance. Cancer Res. 2020;80(16):3222–35.
5. Zhang H, Jiang H, Zhang H, Liu J, Hu X, Chen L. Ribophorin II potentiates P-glycoprotein- and ABCG2-mediated multidrug resistance via activating ERK pathway in gastric cancer. Int J Biol Macromol. 2019;128:574–82.